Inflazyme Pharmaceuticals Ltd.
TSX : IZP

Inflazyme Pharmaceuticals Ltd.

September 01, 2005 18:21 ET

Inflazyme Pharmaceuticals Ltd. to Hold Annual General Meeting on September 8, 2005

VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - Sept. 1, 2005) - Inflazyme Pharmaceuticals Ltd. (TSX:IZP) will be holding its Annual General Meeting on Thursday, September 8, 2005 beginning at 10:00 am PST (1:00 pm EST). The annual general meeting will be held in the Garden View Room of the Richmond Inn in Richmond, B.C., Canada. Dr. Kevin Mullane, President and Chief Executive Officer of Inflazyme, will host a year-in-review presentation to shareholders.

Dr. Mullane's presentation, together with an audio recording, will be available on Inflazyme's website at www.inflazyme.com.

Inflazyme is a Vancouver based biopharmaceutical company focused on developing new therapies for the treatment of respiratory and inflammatory diseases in areas of unmet medical needs. Further information on the Company may be obtained from its website at www.inflazyme.com.

Statements in this news release other than historical information are forward-looking statements subject to risks and uncertainties. Actual results could differ materially depending on factors such as the availability of resources, the timing and effects of regulatory actions, the strength of competition, the outcome of litigation and the effectiveness of patent protection. Additional information regarding risks and uncertainties is set forth in the current Annual Information Form for Inflazyme on file with the Canadian Securities Commissions.


The Toronto Stock Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this information.

Contact Information